A human cytomegalovirus mutant resistant to the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine (BW B759U) induces reduced levels of BW B759U triphosphate

Proceedings of the National Academy of Sciences of the United States of America

Volumn 83, Issue 22, 1986, Pages 8769-8773

  Biron, K K ^a   Fyfe, J A ^a   Stanat, S C ^a   Leslie, L K ^b   Sorrell, J B ^b   Lambe, C U ^b   Coen, D M ^b  

^a GLAXOSMITHKLINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BW B 759 U; GANCICLOVIR; UNCLASSIFIED DRUG;

CELL CULTURE; DRUG ACCUMULATION; DRUG ADMINISTRATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; METHODOLOGY; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS MUTATION;

ACYCLOVIR; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; DRUG RESISTANCE, MICROBIAL; GANCICLOVIR; HUMANS; MUTATION; NUCLEOSIDES; PHOSPHORYLATION; SIMPLEXVIRUS; THYMIDINE KINASE;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 2742573036     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.83.22.8769     Document Type: Article

References (0)